Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 496-498, 2003; 10.1373/49.3.496
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lovicu, M.
Right arrow Articles by Loudianos, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovicu, M.
Right arrow Articles by Loudianos, G.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2003;49:496-498.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

Efficient Strategy for Molecular Diagnosis of Wilson Disease in the Sardinian Population

Mario Lovicu1, Valeria Dessi2, Antonietta Zappu2, Stefano De Virgiliis2,3, Antonio Cao1 and Georgios Loudianos3a

1 Instituto di Neurogenetica e Neurofarmacologia, Consiglio Nazionale Richerche, Cagliari, via Boccaccio 8, 0947 Selagius, Italy

2 Dipartmento di Scienze Biomediche e Biotecnologie, Università di Cagliari, via Jenner s/n, 09121 Cagliari, Italy

3 Ospedale Regionale per Le Microcitemie, Azienda Sanitaria Locale 8, Cagliari, Via Jenner s/n, 09131 Cagliari-Sardegna, Italy

aauthor for correspondence: fax 39-070-503696, e-mail gloudian{at}mcweb.unica.it

Wilson disease (WD) is an autosomal recessive disorder of copper transport resulting from the defective function of a copper-transporting ATPase (ATP7B) (1)(2)(3). More than 200 disease-causing mutations have been identified (4). In the Sardinian population, WD has an incidence of ~1 in 7000 live births (5). Using single-strand conformation polymorphism (SSCP) and sequencing methods for mutation analysis, we have characterized 92% of the chromosomes analyzed and identified 16 different WD-causing mutations, 6 of which (-441/-427del, 213–214delAT, 1512–1513insT, R778W, 2463delC, and V1146M) are relatively common and account for 85% of chromosomes (6). On the basis of these data, we developed a reverse dot-blot (RDB) method as a practical solution to mutation screening in this population.

DNA samples from Sardinian WD patients carrying different combinations of the most common mutations (-441/-427del, 2463delC, V1146M, 213–214delAT, 1512–1513insT, and R778W) were used as controls. Our aim was to obtain the same PCR conditions for all six pairs of primers that were used to amplify the regions containing the six most common mutations. We therefore designed primers with an identical melting temperatures and tested their specificity first in single and then in multiplex PCRs. We also wanted to obtain relatively equal yields for all PCR products to obtain comparable signals using the RDB method. We therefore tested different concentrations for each pair of primers and finally established primer concentrations that allowed us to obtain approximately equal yields for the six PCR products. After repeated experiments and adjustment of the primer lengths and concentrations, we finally obtained six pairs of primers that permitted specific amplification using an annealing temperature of 60 °C (Fig. 1A and Table 1 ). The PCR products ranged from 93 to 430 bp in size (Fig. 1A and Table 1 ). The experiments were performed in 25 µL of 1x buffer containing 1.5 mM MgCl2, 0.2 mM deoxynucleotide triphosphates, 0.05 mM biotin 16-dUTP, and 1 U of Taq polymerase. Primers were used at the concentrations described in Table 1 . The reactions were performed on 100 ng of genomic DNA in a Gene-Amp 2400 (Perkin-Elmer) with an initial denaturation of 5 min at 94 °C, followed by 30 cycles of denaturation for 30 s at 94 °C and annealing for 30 s at 60 °C, with extension for 1 min at 72 °C for each cycle and a final extension of 10 min at 72 °C. After amplification, 5 µL of the PCR mixture was analyzed on a 2% agarose gel.



View larger version (39K):
[in this window]
[in a new window]
 
Figure 1. Multiplex PCR and RDB analysis in Sardinian WD patients.

(A), lane 1, {Phi}X174 marker; lanes 2–6, multiplex PCR products of different WD patients. The amplified regions and the mutations contained in each region are indicated on the right. UTR, untranslated region. (B), examples of DNA analysis of WD patients carrying different combinations for the six most common Sardinian mutations. Samples homozygous for a MT (M) or WT (N) allele hybridize only with the oligonucleotide that detects the respective allele. Heterozygous samples hybridize with both the MT and the WT oligonucleotides. Normal, WT control.


View this table:
[in this window]
[in a new window]
 
Table 1. Oligonucleotides used as primers for WD multiplex PCR and as probes in the RDB assay.

The criteria used to set up the RDB assay were (a) a stringent hybridization to differentiate between oligonucleotides differing by only one base pair and (b) the same hybridization conditions for all wild-type/mutant (WT/MT) oligonucleotide pairs. Different oligonucleotides were synthesized and covalently attached to membranes via an amino linker. By varying the length and by experimentally testing the oligonucleotides, we obtained uniform hybridization conditions for all WT and MT probes at 53 °C. The oligonucleotide concentrations were the second variable investigated. They were tested in the same set of experiments using different concentrations for each probe. The WT oligonucleotide probes, which have a strong signal when hybridized to the WT PCR products and no signal when hybridized to the MT PCR products, were chosen as the WT probe; those that gave no signal when hybridized to WT products and a strong signal when hybridized to MT PCR products were chosen as the MT probes (Fig. 1BUp ). This was repeated for all six mutations. The sequences and the concentrations of the oligonucleotides used in the final assay are given in Table 1Up .

Preparation of the Biodyne C membrane (Pall BioSupport) was essentially as described by Zang et al. (7). The membrane strips were prehybridized in 3 mL of 2x standard saline citrate, pH 7, containing 1 g/L sodium dodecyl sulfate in a plastic bag at 53 °C for 15 min. We denatured 20 µL of each multiplex PCR product at 95 °C for 10 min, put the denatured products on ice for 5 min, added the hybridization solution, and incubated the products individually with the membrane strips at 53 °C for 1 h. After hybridization, the strips were washed with 5 mL of fresh hybridization solution at 53 °C for 10 min. After washing, strips were incubated with 5 mL of fresh hybridization solution containing 3 units of streptavidin-alkaline phosphatase conjugate at room temperature for 30 min. Excess conjugate was removed with two 5-min washes in 0.1 mol/L diethanolamine, pH 10, containing 1 mmol/L MgCl2 and 0.1 g/L sodium azide. The strips were then incubated in the dark with 0.1 mol/L Tris, pH 9.5, containing 0.1 mol/L NaCl, 50 mmol/L MgCl2, 0.6 mg of nitroblue tetrazolium, and 0.3 mg of 5-bromo-4-chloro-3-indolyl phosphate for 30 min, after which the strips were blocked with a 5 mL of 20 mmol/L Tris, pH 7.5, containing 5 mmol/L EDTA.

In this study, exploiting the allelic homogeneity of WD in this population, we developed a RDB system that simplifies mutation screening because by screening for only the six most common mutations, we cover 85% of the total number of WD chromosomes.

Using the RDB method and SSCP analysis, we analyzed 63 individuals referred to our center for molecular analysis of WD. The obtained results agreed with both the RDB and the SSCP methods of analysis (our unpublished data). In our hands, the RDB assay is a rapid, sensitive, and easy system for screening multiple mutations in a single assay and allows testing for the majority of WD defects (85%) in this population. Another advantage of the RDB assay is that one patient can be screened with only one strip. This minimizes sample confusion in all of the steps. On the basis of these data, we can conclude that the most efficient strategy in the molecular diagnosis of WD in the Sardinian population is a first-step mutation screening for the six most common mutations with multiplex PCR followed by RDB analysis. Samples not characterized with this first step will be subsequently characterized by SSCP analysis of all of the exons and the promoter region of the ATP7B gene.


Acknowledgments

This work was supported by grants from Assessorato Igiene e Sanità Regione Sardegna-L.R (11.30.04.1990) and Programa di Educazione Sanitaria (DGR 1380/98-60% and 40%-97) to A. Cao.


References

  1. Danks M. Disorders of copper transport. Scriver CR Beaudet AL Sly WS Valle D eds. The metabolic bases of inherited diseases, 6th ed 1989;Vol. 1:1416-1422 McGraw-Hill New York. .
  2. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327-335.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  3. Tanzi RE, Petrukhin K, Chernov I, Pellequr JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:344-350.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  4. University of Alberta Department of Medical Genetics. http://www.uofa-medical-genetics.org (accessed September 30, 2002)..
  5. De Virgiliis S. Prevenzione della malattia di Wilson [Abstract]. Workshop sulla "diagnosi precoce di malattie genetiche e della suscettibilità ereditaria allo sviluppo di neoplasie: proposte per una programmazione sanitaria." Istituto Superiore Sanità, 18–19 Dicembre 1997, Roma:40..
  6. Loudianos G, Dessi V, Lovicu M, Angius A, Figus AL, Lilliu F, et al. Molecular characterization of Wilson disease in the Sardinian population-evidence of a founder effect. Hum Mutat 1999;14:294-303.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  7. Zhang Y, Coyne MY, Will SG, Levenson CH, Kawasaki ES. Single base mutational analysis of cancer and genetic diseases using membrane bound modified oligonucleotides. Nucleic Acids Res 1991;19:3929-3933.[Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
C. M. Mak, C.-W. Lam, and S. Tam
Diagnostic Accuracy of Serum Ceruloplasmin in Wilson Disease: Determination of Sensitivity and Specificity by ROC Curve Analysis among ATP7B-Genotyped Subjects
Clin. Chem., August 1, 2008; 54(8): 1356 - 1362.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lovicu, M.
Right arrow Articles by Loudianos, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovicu, M.
Right arrow Articles by Loudianos, G.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS